Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc
Journal website https://jmc.elmerpub.com

Case Report

Volume 000, Number 000, January 2026, pages 000-000


Intravenous Thiamine-Induced Thrombocytopenia in a Patient With Chronic Adrenal Insufficiency

Tables

Table 1. Baseline Laboratory Values (Day 0)
 
ParameterValueReference range
WBC: white blood cell; MCV: mean corpuscular volume.
Hemoglobin13.3 g/dL12.5 - 16.5 g/dL
WBC7.5 × 109/L4.0 - 11.0 × 109/L
Platelets225 × 109/L150 - 450 × 109/L
MCV96 fL78 - 98 fL
Reticulocytes1.2%0.5-2.5%

 

Table 2. Platelet Count Timeline and Common Terminology Criteria for Adverse Events (CTCAE) Grading
 
DayInterventionPlatelet count (× 109/L)% ChangeCTCAE grade
0 (baseline)Before thiamine (day of initiation)22500
1Day 1 after thiamine started150-33%0
2Day 2 - thiamine continued110-51%0
3Day 3 - thiamine continued86-62%Grade 1
4Day 4 - thiamine continued63-72%Grade 2
5Day 5 - thiamine continued48-79%Grade 3
6Day 6 - thiamine stopped65+35%Grade 2
7Day 7 - post-cessation88+83%Grade 2
8Day 8 - post-cessation132+175%Grade 1
14Day 14 - follow-up (2 weeks)265Complete recovery0

 

Table 3. Systematic Exclusion of Alternative Causes
 
ConditionInvestigationsResultsConclusion
DIC: disseminated intravascular coagulation; HIT: heparin-induced thrombocytopenia; TTP: thrombotic thrombocytopenic purpura; HUS: hemolytic uremic syndrome; HIV: human immunodeficiency virus; Hep C: hepatitis C virus; Hep B: hepatitis B virus; RBC: red blood cell; CRP: C-reactive protein; PT: prothrombin time; aPTT: activated partial thromboplastin time; INR: international normalized ratio; ANA: antinuclear antibody; ESR: erythrocyte sedimentation rate; LDH: lactate dehydrogenase; CBC: complete blood count; HIV Ag/Ab test: human immunodeficiency virus antigen/antibody test; anti-HCV antibody: hepatitis C virus antibody; HBsAg: hepatitis B surface antigen; anti-HBc: hepatitis B core antibody; anti-HBs: hepatitis B surface antibody; AST: aspartate aminotransferase; ALT: alanine aminotransferase; GGT: gamma-glutamyl transferase.
SepsisVitals, CRP, blood culturesBP 135/88, CRP 0.88 mg/dL, cultures negativeExcluded
DICPT, aPTT, INR, fibrinogen, D-dimerPT 10 s, aPTT 26 s, INR 0.9, Fib 360 mg/dL, D-dimer 0.50Excluded
HITHeparin exposure, 4T scoreNo heparin exposure, 4T score = 0Excluded
AutoimmuneANA, Coombs, ESRANA negative, Coombs negative, ESR 18Excluded
TTP/HUSLDH, haptoglobin, schistocytesLDH 160 IU/L, haptoglobin 52 mg/dL, no schistocytesExcluded
Bone marrowCBC, peripheral smearIsolated thrombocytopenia, normal morphologyExcluded
HIV infection, Hep C, and Hep BHIV Ag/Ab test, anti-HCV antibody, HBsAg, anti-HBc, and anti-HBsNegative, negative, negative, negative, and positiveExcluded and vaccinated Hep B
Liver function testAST, ALT, alkaline phosphatase, GGT, total bilirubin34 U/L, 38 U/L, 56 U/L, 22U/L, 1.1 mg/dLNormal test
Renal function and electrolytesCreatinine, urea, Na, K, Cl, Mg, Ca1.1 mg/dL, 22 mg/dL, 134 mmol/L, 3.7 mmol/L, 99 mmol/L, 1.9 mg/dL, 9.3 mg/dLBorderline test
Vitamin B12 and folateSerum values of vitamin B12 and folate369 pmol/L, 14 ng/mLNormal
RBC countRBC count5.1 × 106/µLNormal